Skip to main content

Table 1 DNL-Rap conjugates used in the study

From: Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer

Code

Target

AD2-module

DDD2-module

(Rap)2-E1-(Rap)2

Trop-2

CH3-AD2-IgG-hRS7

Rap-DDD2

(Rap)2-22-(Rap)2

CD22

CH3-AD2-IgG-hLL2

Rap-DDD2

(Rap)2-20-(Rap)2

CD20

CH3-AD2-IgG-hA20

Rap-DDD2

(Rap)2-74-(Rap)2

CD74

CH3-AD2-IgG-hLL1

Rap-DDD2

(Rap)2-C2ā€“(Rap)2

HLA-DR

CH3-AD2-IgG-hL243

Rap-DDD2

(Rap)2-14-(Rap)2

CEACAM5

CH3-AD2-IgG-hMN-14

Rap-DDD2

(Rap)2-E1*-(Rap)2

Trop-2

CK--AD2-IgG-hRS7

Rap-DDD2

(Rap)2-22*-(Rap)2

CD22

CK-AD2-IgG-hLL2

Rap-DDD2